Back to search

Canada· CA-DIN-02359685

BIACNA TOPICAL GEL

A clindamycin, kombinationen product containing tretinoin + clindamycin phosphate, registered in Canada by BAUSCH HEALTH, CANADA INC.. The same ATC class is registered in 10 of our 19 countries.

ATC D10AF51

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedBIACNA TOPICAL GELATCD10AF51REGISTER NO.CA-DIN-02359685PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Clindamycin, kombinationen is registered in 10 of 19 countries.

Countries holding a registration under ATC D10AF51 (clindamycin, kombinationen), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 6 of them publish a price we can compare per daily dose

Clindamycin, kombinationen · ATC D10AF51

10 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
TRETINOIN + CLINDAMYCIN PHOSPHATE
Manufacturer
BAUSCH HEALTH, CANADA INC.
Country
Canada (CA)
ATC code
D10AF51
ATC class
Clindamycin, Kombinationen
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Clindamycin, kombinationen in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All clindamycin, kombinationen products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

  • Austria · Acnatac
  • Belgium · Treclinax
  • Bulgaria · Акнатак
  • Cyprus · Acnatac
  • Czechia · Acnatac
  • Germany · Acnatac
  • Denmark · Acnatac
  • Estonia · Treclinac
  • Spain · Treclinac
  • Finland · Acnatac
  • France · Zanea
  • United Kingdom (Northern Ireland) · Treclin
  • Greece · Acnatac, Treticlin
  • Ireland · Treclin
  • Iceland · Acnatac
  • Italy · Acnatac
  • Lithuania · Treclinac
  • Luxembourg · Treclinax
  • Latvia · Treclinac
  • Malta · Acnatac
  • Netherlands · Treclinac
  • Norway · Zalna
  • Poland · Acnatac
  • Portugal · Acnatac
  • Romania · Acnatac
  • Sweden · Acnatac
  • Slovenia · Zalna
  • Slovakia · Acnatac

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/af0c6014-7881-47ef-8dad-f7222fc028f1
GET /v1/drugs/af0c6014-7881-47ef-8dad-f7222fc028f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "02359685",
  "form": "GEL",
  "class": "Human",
  "routes": [
    "TOPICAL"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "D10AF51",
  "schedule": [
    "Prescription"
  ],
  "drug_code": "84468",
  "strengths": [
    "0.025 %",
    "1.2 %"
  ],
  "ahfs_class": null,
  "substances": [
    "TRETINOIN",
    "CLINDAMYCIN PHOSPHATE"
  ],
  "product_categorization": null
}

See everything about clindamycin, kombinationen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.